Sonnet BioTherapeutics, a biotech firm listed on Nasdaq, has announced a business combination with Rorschach, a newly formed entity, to establish a digital asset treasury focused on the Hyperliquid (HYPE) token. The company disclosed the agreement on Monday, confirming the launch of Hyperliquid Strategies Inc. as part of the initiative. Upon closing, the new entity […]
The post Sonnet BioTherapeutics Bets Big on HYPE Token as Charts Signal 161% Rally Potential appeared first on CoinChapter.
